Search | IOVS | ARVO Journals

View

Showing 1 – 1 of 1

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Anti-VEGF/anti-angiopoietin-2 bispecific antibody RG7716 in diabetic macular edema: complete 36-week results from the phase 2, multicenter, randomized, active treatment-controlled BOULEVARD clinical trial

Sunil S Patel; Jayashree Sahni; Shamil Sadikhov; Meike Pauly-Evers; Piotr Szczesny; Robert Weikert

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1959. doi:

Advertisement